Melatonin fails to modulate immune parameters influenced by calorie restriction in aging Fischer 344 rats

被引:13
作者
Pahlavani, MA
Vargas, DA
Evans, TR
Shu, JH
Nelson, JF
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78229 USA
[2] Audie L Murphy Mem Vet Adm Med Ctr, S Texas Vet Hlth Care Syst, Ctr Geriatr Res Educ & Clin, San Antonio, TX 78229 USA
关键词
melatonin; caloric restriction; immunomodulation; aging; rat;
D O I
10.1177/153537020222700308
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
The aim of this study was to determine if long-term treatment with melatonin (MEL), a purported anti-aging agent, was as effective as calorie restriction (CR) in modulating immune parameters in aging Fischer 344 male rats. Splenic lymphocytes were isolated from 17-month-old rats that, beginning at 6 weeks of age, were treated with MEL (4 or 16 mug/ml in drinking water) and from 17-month-old rats fed ad libitum (AL) or rats fed a CR diet (55% of AL intake). The number of splenic T cell populations and T cell subsets was measured by flow cytometry, the proliferative response of splenocytes to Concanavalin A (Con A) and lipopolysaccharide (LPS) was measured by [H-3]thymidine incorporation, and the induction of cytokine production (IL-2 and IFN-gamma) was measured by ELISA assay. In addition, the level of the natural killer (NK) cell activity was assessed by fluorimetric assay. CR rats had a higher number of lymphocytes expressing the naive T cell marker (CD3 OX22) than AL rats (P < 0.05). CR rats also showed greater induction of proliferative response, IL-2 and IFN-γ levels following Con A simulation, and NK cell activity than AL rats (P < 0.05). MEL-treated rats did not differ from AL rats in any of these parameters or in any other measurement. These results indicate that MEL treatment is unable to modulate immune function in a manner comparable with that of CR.
引用
收藏
页码:201 / 207
页数:7
相关论文
共 45 条
[1]
Angeli A., 1988, PINEAL GLAND CANCER, P145
[2]
[Anonymous], LIFE SCI
[3]
IMMUNOMODULATION BY INDOLEAMINES - SEROTONIN AND MELATONIN ACTION ON DNA AND INTERFERON-GAMMA SYNTHESIS BY HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
ARZT, ES ;
FERNANDEZCASTELO, S ;
FINOCCHIARO, LME ;
CRISCUOLO, ME ;
DIAZ, A ;
FINKIELMAN, S ;
NAHMOD, VE .
JOURNAL OF CLINICAL IMMUNOLOGY, 1988, 8 (06) :513-520
[4]
Melatonin: immune modulation of spleen cells in young, middle-aged and senescent mice [J].
Atre, D ;
Blumenthal, EJ .
MECHANISMS OF AGEING AND DEVELOPMENT, 1998, 103 (03) :255-268
[5]
MELATONIN RESTORES IMMUNODEPRESSION IN AGED AND CYCLOPHOSPHAMIDE-TREATED MICE [J].
CAROLEO, MC ;
DORIA, G ;
NISTICO, G .
AGING CLOCK: THE PINEAL GLAND AND OTHER PACEMAKERS IN THE PROGRESSION OF AGING AND CARCINOGENESIS, 1994, 719 :343-352
[6]
The clinical neuroimmunotherapeutic role of melatonin in oncology [J].
Conti, A ;
Maestroni, GJM .
JOURNAL OF PINEAL RESEARCH, 1995, 19 (03) :103-110
[7]
CRISTINA MC, 1992, IMMUNOPHARMACOLOGY, V23, P81
[8]
KOLITZ JE, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1607
[9]
Melatonin increases gene expression for antioxidant enzymes in rat brain cortex [J].
Kotler, M ;
Rodríguez, C ;
Sáinz, RM ;
Antolín, I ;
Menéndez-Peláez, A .
JOURNAL OF PINEAL RESEARCH, 1998, 24 (02) :83-89
[10]
LUCAS LC, 1992, IMMUNOL LETT, V33, P123